Aislinn Antrim, Assistant Editor

Despite opportunity to save money with generic medications, many patients do not understand the options.

In addition to its potential uses in cancer treatment, this novel drug delivery system could be used with magnetic resonance imaging or fluorescence imaging.

As increasing numbers of COVID-19 patients require intubation, aerosol containment devices have been in high demand, including improvised protection strategies and devices.

Contrary to earlier data, a new study from the University of California at San Francisco (UCSF) suggests that younger age may not reduce the severity of coronavirus disease 2019 (COVID-19).

Results of the COVID-19 and Cancer Consortium cohort study were presented during the 2020 American Society of Clinical Virtual Scientific Program.

Investigators have found that shear stress caused by aortic valve stenosis activates white blood cells, leading to potentially harmful inflammation, which in turn accelerates heart disease.

As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.

Despite the scientific evidence of the vaccine’s benefits, 45% of the posts had a negative tone toward people getting the vaccine.

Investigators have found that although the composition and function the gut microbiome changes throughout the day in most people, these variations stop in patients with type 2 diabetes (T2D).

Heldenbrand said many patients look to the internet for answers and increasing numbers of patients are turning to YouTube.

The human papillomavirus infection (HPV) vaccine should be administered in 2 doses for children between 9 and 12 years of age, according to updated guidelines from the American Cancer Society (ACS).

Results were announced at the virtual 23rd International AIDS Conference.

Critically ill patients admitted to the intensive care unit (ICU) with coronavirus disease 2019 (COVID-19) are 10 times more likely to develop cardiac arrhythmias.

In addition to finding that depression affects up to 70% of women transitioning into menopause, investigators have also identified the greatest risk factors.

Autoimmune diseases in general affect women more frequently than men, and thyroid disease, in particular, is very common.

Urothelial carcinoma accounts for approximately 90% of all bladder cancers and becomes increasingly challenging to treat as it spreads through the layers of the bladder wall.

According to a press release, this is the first single-agent, anti-PD-1 therapy approved in the first-line environment for this patient population.

Remdesivir, the investigational drug for the treatment of the coronavirus disease 2019 (COVID-19), will be sold for $390 per vial.

One in 8 women will develop breast cancer within their lifetime, making it the most commonly diagnosed cancer among women.

Current research has already found that CVD is among the most common pre-existing conditions among people who die from COVID-19.

According to the survey results, not only do a majority of the 500 respondents experience fear of bleeding events, but many of them also avoid or modify activities in order to mitigate their risk.

According to the investigators, payers and employers are increasingly adopting HDHPs in an effort to control rising health care costs.

Cognitive impairment is extremely common among patients with MS, affecting approximately two-thirds of this patient population.

Although some of the largest insurers have waived their cost sharing requirements, employer-sponsored “self-insured” health insurance plans are not required to adhere to these waivers.

Women diagnosed with breast cancer while breastfeeding may receive treatments that decrease milk production or are contraindicated.

Planning on how to address drug and equipment shortages will be essential to continuing patient care in the coming months.

After up to 4.8 years of treatment with nusinersen, 100% of children with spinal muscular atrophy (SMA) who were treated pre-symptomatically are still alive.

With new and varying options for maintenance therapy in patients with ovarian cancer, patients may express a preference when discussing potential maintenance treatments and their adverse effects.

The authors posited that teriflunomide could prevent an excessive immune response while still maintaining enough defense against the virus.

The FDA has approved tazemetostat for the treatment of 2 different follicular lymphoma (FL) indications.